CDER director Patrizia Cavazzoni, FDA commissioner Robert Califf and OPDP acting director Catherine Gray
Drug promotion enforcement so far similar under new FDA chief, with just 4 letters in first half of 2022
Will a trio of new bosses at the FDA lead to an increase in drug advertising enforcement? It’s a good question, but with few letters …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
